Mark J. Gergen, Executive VP, COO at Mirati Therapeutics, Inc. (MRTX), sold 20,000 shares at $25.92 ($518K) on 2016-01-15, disclosed to the SEC on 2016-01-19.
Open-market sale of $518k MRTX by Executive VP, COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.92 | 10,000 | $259K | 50.0% |
| 2 | $25.92 | 10,000 | $259K | 50.0% |
| Total | $25.92 avg | 20,000 | $518K | 100% |
| Filing → |
| AMLN | SELL | 2012-03-02 | $32K | — | Filing → |
| AMLN | SELL | 2012-02-24 | $128K | — | Filing → |
| AMLN | SELL | 2007-11-02 | $22K | — | Filing → |